These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 16719150

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
    Mavroudis D.
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M, Villar Chamorro E, Alés Díaz I, Gil Calle S, Alcalde García J, Gutiérrez Calderón V, Carabantes Ocón F, Montesa Pino A, Bretón García JJ, Benavides Orgaz M.
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [Abstract] [Full Text] [Related]

  • 7. [New data presented at ASCO 2002 concerning non-small cell bronchial cancers].
    Morère JF.
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S5-10. PubMed ID: 12538925
    [No Abstract] [Full Text] [Related]

  • 8. [Chemotherapy of stage IV non-small-cell lung cancer: contribution of gemcitabine].
    Souquet PJ, Gérinière L.
    Rev Pneumol Clin; 2000 Nov; 56(5):315-9. PubMed ID: 11139761
    [Abstract] [Full Text] [Related]

  • 9. The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).
    Waters JS, O'Brien ME.
    Br J Cancer; 2002 Aug 27; 87(5):481-90. PubMed ID: 12189541
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.
    Comella P, Frasci G, Carnicelli P, Massidda B, Buzzi F, Filippelli G, Maiorino L, Guida M, Panza N, Mancarella S, Cioffi R.
    Br J Cancer; 2004 Aug 02; 91(3):489-97. PubMed ID: 15266334
    [Abstract] [Full Text] [Related]

  • 12. A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC).
    Ginopoulos P, Mastronikolis NS, Giannios J, Karana A, Siabi V, Karvelas F, Rathossis S, Apostolopoulos N, Mastorakou A.
    Lung Cancer; 1999 Jan 02; 23(1):31-7. PubMed ID: 10100144
    [Abstract] [Full Text] [Related]

  • 13. [Gemcitabine].
    Takeda K.
    Nihon Rinsho; 2002 May 02; 60 Suppl 5():359-65. PubMed ID: 12101689
    [No Abstract] [Full Text] [Related]

  • 14. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
    Greco FA, Gray JR, Thompson DS, Burris HA, Erland JB, Barton JH, Litchy S, Houston GA, Butts JA, Webb C, Scott C, Hainsworth JD.
    Cancer; 2002 Sep 15; 95(6):1279-85. PubMed ID: 12216096
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A, Scott DA, Hewitson P, Sidhu M, Waugh N.
    Thorax; 2002 Jan 15; 57(1):20-8. PubMed ID: 11809985
    [Abstract] [Full Text] [Related]

  • 18. Lung cancer: therapeutic options for stage IV and recurrent NSCLC.
    Calvo AR, Belani CP.
    Cancer Treat Res; 2001 Jan 15; 105():189-227. PubMed ID: 11224988
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].
    Grossi F, de Marinis F, Frontini L, Gridelli C.
    Tumori; 2008 Jan 15; 94(3):5-14. PubMed ID: 18705422
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.